TP53 and cancer: The results suggested that the genes of the high-risk group enriched in the cell cycle, the p53 signaling pathway, pathways in cancer, the Notch signaling pathway, the WNT signaling pathway, and the TGF-beta signaling pathway increased (Figure S4).